Avermectin is a group of compounds derived from the soil bacteria Streptomyces avermitilis. These compounds are commonly used as insecticides and antiparasitic agents in agriculture and veterinary medicine. It works by binding to certain receptors in the nervous system of insects and parasites, which causes paralysis and death. It is particularly effective against nematode worms, such as those that cause river blindness and other parasitic diseases in humans and animals. It is also used to control mites and other insects in crops such as fruits, vegetables, and ornamental plants.
One of the most well-known avermectins is ivermectin, which is commonly used to treat parasitic infections in humans and animals. Ivermectin has been shown to be effective against a range of parasites, including lice, scabies, and certain types of worms. However, it is important to note that ivermectin should only be used under the supervision of a healthcare professional, as it can cause serious side effects if used improperly.
In recent years, there has been a growing demand for organic and natural products due to concerns about the potential health and environmental impacts of synthetic pesticides. Consumers are increasingly aware of the potential risks associated with exposure to pesticides, and are seeking out safer and more sustainable alternatives. Avermectin is a naturally occurring compound that is derived from soil bacteria and is highly effective against pests. It has a low impact on the environment and is considered a safe and effective alternative to synthetic pesticides. As a result, it has become a popular choice among growers and consumers.
One example of the increasing demand for organic and natural products is the growth of the organic food industry. According to the Organic Trade Association, the U.S. organic food market reached a record $56.4 billion in sales in 2020, up 12.4% from the previous year. This growth is being driven by consumers who are seeking out healthier and more sustainable food options.
In response to this growing demand, many companies are developing new and innovative products that are made with natural and organic ingredients, including those that contain avermectin. For example, there are now organic and natural insecticides on the market that are made with avermectin, which are highly effective against pests and are safe for use around humans and pets.
Advances in biotechnology and genetic engineering have revolutionized the production of avermectin, making it more efficient and cost-effective than traditional methods. These developments have resulted in the creation of new strains of bacteria that are optimized for avermectin production, and have helped to increase the availability of these products in the market.
One example of these technological advancements is the use of synthetic biology to engineer bacteria for the production of avermectin. Researchers are using genetic engineering techniques to modify the genetic makeup of bacteria, which allows them to produce larger quantities of avermectin with higher purity and at a lower cost. Another example is the use of fermentation technology to produce avermectin. Fermentation is a process in which bacteria are grown in large vats or tanks, and is used to produce a wide range of products, including pharmaceuticals, food additives, and industrial chemicals. By optimizing the fermentation process, researchers are able to produce larger quantities of avermectin at a lower cost.
In addition to these developments, there are also efforts underway to improve the delivery and application of avermectin products. For example, researchers are exploring the use of nanotechnology to create more effective and targeted delivery systems for avermectin, which could help to reduce the amount of product needed and minimize environmental impacts.
New product launches to flourish in the market
In 2021, Syngenta launched its new Talon insecticide, which is made with abamectin, a derivative of avermectin. The product is designed to control a wide range of pests, including mites, thrips, and whiteflies, and is registered for use in several crops, including vegetables, fruits, and ornamentals. In 2020, FMC Corporation launched its new Hero insecticide, which is made with bifenthrin and abamectin. The product is designed to provide broad-spectrum control of pests, including aphids, caterpillars, and thrips, and is registered for use in several crops, including soybeans, corn, and cotton. In 2019, DowDuPont (now Corteva Agriscience) launched its new Delegate insecticide, which is made with spinetoram, a compound that is structurally related to avermectin. The product is designed to provide fast-acting control of a wide range of pests, including caterpillars, beetles, and aphids, and is registered for use in several crops, including vegetables, fruits, and nuts.
Segment Overview:
By application: The avermectin market is divided into thread worm infestation, river blindness disease, round worm infestation, whipworm infestation, and others. Thread worm infestation, round worm infestation, whipworm infestation, and river blindness disease are the major segments of this market. Each of these segments represents a specific type of parasite or disease that can be treated using avermectin-based products. In addition, there are other minor segments in the market that are targeted by avermectin products. These segments may include other parasitic infestations that are less common or less severe. Overall, this market provides effective solutions for a range of parasitic infestations and diseases, improving the health and well-being of people and animals alike.
By form: The avermectin market is classified into tablet and others. This market is a broad market that is classified into various segments based on the forms in which the drug is available. One of the major segments of this market is the tablet segment, which refers to this drug in tablet or oral form. These tablets are widely used for the treatment of various parasitic infestations and diseases in humans and animals. The tablets are easy to administer, convenient, and provide effective results in a short period. Besides, there are other forms of avermectin products available in the market, including topical solutions, injectables, and other formulations. These other forms of avermectin products cater to different needs and preferences of customers, providing a wide range of options to choose from.
By distribution channel: The avermectin market is classified into retail pharmacies, hospital pharmacies, and online pharmacies. One of the significant segments of this market is the retail pharmacies segment, which refers to the physical stores where avermectin products are sold to the customers. Retail pharmacies provide easy access to avermectin drugs and are often the first choice for consumers to purchase medicines. The hospital pharmacies segment refers to the pharmacies located within the hospitals that provide avermectin drugs to the patients. Hospital pharmacies offer avermectin products to the patients during their hospital stay or for outpatient treatment. Finally, the online pharmacies segment refers to the digital platforms that sell avermectin products online to the consumers.
By region: The Asia-Pacific avermectin market is a significant market in the global avermectin market. The Asia-Pacific region comprises countries such as China, India, Japan, Australia, and others. The market in this region is driven by the high prevalence of parasitic diseases in both humans and animals, increasing awareness regarding animal healthcare, and rising demand for safe and effective medications. In addition, the presence of several key market players in the region, coupled with the growing investments in R&D activities, is expected to fuel the growth of this market in the Asia-Pacific.
Competitive analysis and profiles of the major players in the avermectin market, such as Aegis Pharmaceuticals, AHPL, Biotavia Labs Pvt. Ltd., Captab Biotec, DKSH, Elfin Pharma Pvt. Ltd., Merck, Xi'an Tian Guangyuan Biotech Co. Ltd, and Zee Laboratories Ltd. Major players have adopted product launch and acquisition as key developmental strategies to improve the product portfolio of the construction equipment market.
One of the most well-known avermectins is ivermectin, which is commonly used to treat parasitic infections in humans and animals. Ivermectin has been shown to be effective against a range of parasites, including lice, scabies, and certain types of worms. However, it is important to note that ivermectin should only be used under the supervision of a healthcare professional, as it can cause serious side effects if used improperly.
In recent years, there has been a growing demand for organic and natural products due to concerns about the potential health and environmental impacts of synthetic pesticides. Consumers are increasingly aware of the potential risks associated with exposure to pesticides, and are seeking out safer and more sustainable alternatives. Avermectin is a naturally occurring compound that is derived from soil bacteria and is highly effective against pests. It has a low impact on the environment and is considered a safe and effective alternative to synthetic pesticides. As a result, it has become a popular choice among growers and consumers.
One example of the increasing demand for organic and natural products is the growth of the organic food industry. According to the Organic Trade Association, the U.S. organic food market reached a record $56.4 billion in sales in 2020, up 12.4% from the previous year. This growth is being driven by consumers who are seeking out healthier and more sustainable food options.
In response to this growing demand, many companies are developing new and innovative products that are made with natural and organic ingredients, including those that contain avermectin. For example, there are now organic and natural insecticides on the market that are made with avermectin, which are highly effective against pests and are safe for use around humans and pets.
Advances in biotechnology and genetic engineering have revolutionized the production of avermectin, making it more efficient and cost-effective than traditional methods. These developments have resulted in the creation of new strains of bacteria that are optimized for avermectin production, and have helped to increase the availability of these products in the market.
One example of these technological advancements is the use of synthetic biology to engineer bacteria for the production of avermectin. Researchers are using genetic engineering techniques to modify the genetic makeup of bacteria, which allows them to produce larger quantities of avermectin with higher purity and at a lower cost. Another example is the use of fermentation technology to produce avermectin. Fermentation is a process in which bacteria are grown in large vats or tanks, and is used to produce a wide range of products, including pharmaceuticals, food additives, and industrial chemicals. By optimizing the fermentation process, researchers are able to produce larger quantities of avermectin at a lower cost.
In addition to these developments, there are also efforts underway to improve the delivery and application of avermectin products. For example, researchers are exploring the use of nanotechnology to create more effective and targeted delivery systems for avermectin, which could help to reduce the amount of product needed and minimize environmental impacts.
New product launches to flourish in the market
In 2021, Syngenta launched its new Talon insecticide, which is made with abamectin, a derivative of avermectin. The product is designed to control a wide range of pests, including mites, thrips, and whiteflies, and is registered for use in several crops, including vegetables, fruits, and ornamentals. In 2020, FMC Corporation launched its new Hero insecticide, which is made with bifenthrin and abamectin. The product is designed to provide broad-spectrum control of pests, including aphids, caterpillars, and thrips, and is registered for use in several crops, including soybeans, corn, and cotton. In 2019, DowDuPont (now Corteva Agriscience) launched its new Delegate insecticide, which is made with spinetoram, a compound that is structurally related to avermectin. The product is designed to provide fast-acting control of a wide range of pests, including caterpillars, beetles, and aphids, and is registered for use in several crops, including vegetables, fruits, and nuts.
Segment Overview:
By application: The avermectin market is divided into thread worm infestation, river blindness disease, round worm infestation, whipworm infestation, and others. Thread worm infestation, round worm infestation, whipworm infestation, and river blindness disease are the major segments of this market. Each of these segments represents a specific type of parasite or disease that can be treated using avermectin-based products. In addition, there are other minor segments in the market that are targeted by avermectin products. These segments may include other parasitic infestations that are less common or less severe. Overall, this market provides effective solutions for a range of parasitic infestations and diseases, improving the health and well-being of people and animals alike.
By form: The avermectin market is classified into tablet and others. This market is a broad market that is classified into various segments based on the forms in which the drug is available. One of the major segments of this market is the tablet segment, which refers to this drug in tablet or oral form. These tablets are widely used for the treatment of various parasitic infestations and diseases in humans and animals. The tablets are easy to administer, convenient, and provide effective results in a short period. Besides, there are other forms of avermectin products available in the market, including topical solutions, injectables, and other formulations. These other forms of avermectin products cater to different needs and preferences of customers, providing a wide range of options to choose from.
By distribution channel: The avermectin market is classified into retail pharmacies, hospital pharmacies, and online pharmacies. One of the significant segments of this market is the retail pharmacies segment, which refers to the physical stores where avermectin products are sold to the customers. Retail pharmacies provide easy access to avermectin drugs and are often the first choice for consumers to purchase medicines. The hospital pharmacies segment refers to the pharmacies located within the hospitals that provide avermectin drugs to the patients. Hospital pharmacies offer avermectin products to the patients during their hospital stay or for outpatient treatment. Finally, the online pharmacies segment refers to the digital platforms that sell avermectin products online to the consumers.
By region: The Asia-Pacific avermectin market is a significant market in the global avermectin market. The Asia-Pacific region comprises countries such as China, India, Japan, Australia, and others. The market in this region is driven by the high prevalence of parasitic diseases in both humans and animals, increasing awareness regarding animal healthcare, and rising demand for safe and effective medications. In addition, the presence of several key market players in the region, coupled with the growing investments in R&D activities, is expected to fuel the growth of this market in the Asia-Pacific.
Competitive analysis and profiles of the major players in the avermectin market, such as Aegis Pharmaceuticals, AHPL, Biotavia Labs Pvt. Ltd., Captab Biotec, DKSH, Elfin Pharma Pvt. Ltd., Merck, Xi'an Tian Guangyuan Biotech Co. Ltd, and Zee Laboratories Ltd. Major players have adopted product launch and acquisition as key developmental strategies to improve the product portfolio of the construction equipment market.
Avermectin Market, by Application Report Highlights
| Aspects | Details |
 By Application |
|
 By Form |
|
 By Distribution Channel |
|
 By Region |
|
 Key Market Players | Merck, BIOTAVIA LABS PVT. LTD., Xi'an Tian Guangyuan Biotech Co.,Ltd, zee laboratories ltd., ahpl, dksh, Aegis Pharmaceuticals, Elfin Pharma Pvt. Ltd., Captab Biotec |
Loading Table Of Content...
